Competitive athletes with implantable cardioverter-defibrillators-How to program? Data from the Implantable Cardioverter-Defibrillator Sports Registry.

Athletes Cardiac arrest Implantable cardioverter–defibrillator Implantable cardioverter–defibrillator programming Sports participation Ventricular fibrillation Ventricular tachycardia

Journal

Heart rhythm
ISSN: 1556-3871
Titre abrégé: Heart Rhythm
Pays: United States
ID NLM: 101200317

Informations de publication

Date de publication:
04 2019
Historique:
received: 06 08 2018
pubmed: 6 11 2018
medline: 6 10 2020
entrez: 4 11 2018
Statut: ppublish

Résumé

Athletes with an implantable cardioverter-defibrillator (ICD) may require unique optimal device-based tachycardia programming. The purpose of this study was to assess the association of tachycardia programming characteristics of ICDs with occurrence of shocks, transient loss-of-consciousness, and death among athletes. A subanalysis of a prospective, observational, international registry of 440 athletes with ICDs followed for a median of 44 months was performed. Programming characteristics were divided into groups for rate cutoff (very high, high, or low) and detection (long-detection interval [>nominal] or nominal). Endpoints included total, appropriate, and inappropriate shocks, transient loss-of-consciousness, and mortality. In this cohort, 62% were programmed with high-rate cutoff and 30% with long detection. No athlete died of an arrhythmia (related or unrelated) to ICD shocks. Three patients had sustained ventricular tachycardia below programmed detection rate, presenting as palpations and/or dizziness. ICD shocks were received by 98 athletes (64 appropriate, 32 inappropriate); 2 patients received both. Programming a high-rate cutoff was associated with decreased risk of total (P = .01) and inappropriate (P = .04) shocks overall and during competition or practice. Programming long-detection intervals was associated with fewer total shocks. Single- vs dual-chamber devices and the number of zones were unrelated to risk of shock. Transient loss-of-consciousness, associated with 27 appropriate shocks, was not related to programming characteristics. High-rate cutoff and long-detection duration programming of ICDs in athletes at risk for sudden death can reduce total and inappropriate ICD shocks without affecting survival or the incidence of transient loss-of-consciousness.

Sections du résumé

BACKGROUND
Athletes with an implantable cardioverter-defibrillator (ICD) may require unique optimal device-based tachycardia programming.
OBJECTIVE
The purpose of this study was to assess the association of tachycardia programming characteristics of ICDs with occurrence of shocks, transient loss-of-consciousness, and death among athletes.
METHODS
A subanalysis of a prospective, observational, international registry of 440 athletes with ICDs followed for a median of 44 months was performed. Programming characteristics were divided into groups for rate cutoff (very high, high, or low) and detection (long-detection interval [>nominal] or nominal). Endpoints included total, appropriate, and inappropriate shocks, transient loss-of-consciousness, and mortality.
RESULTS
In this cohort, 62% were programmed with high-rate cutoff and 30% with long detection. No athlete died of an arrhythmia (related or unrelated) to ICD shocks. Three patients had sustained ventricular tachycardia below programmed detection rate, presenting as palpations and/or dizziness. ICD shocks were received by 98 athletes (64 appropriate, 32 inappropriate); 2 patients received both. Programming a high-rate cutoff was associated with decreased risk of total (P = .01) and inappropriate (P = .04) shocks overall and during competition or practice. Programming long-detection intervals was associated with fewer total shocks. Single- vs dual-chamber devices and the number of zones were unrelated to risk of shock. Transient loss-of-consciousness, associated with 27 appropriate shocks, was not related to programming characteristics.
CONCLUSION
High-rate cutoff and long-detection duration programming of ICDs in athletes at risk for sudden death can reduce total and inappropriate ICD shocks without affecting survival or the incidence of transient loss-of-consciousness.

Identifiants

pubmed: 30389442
pii: S1547-5271(18)31118-4
doi: 10.1016/j.hrthm.2018.10.032
pii:
doi:

Types de publication

Journal Article Multicenter Study Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

581-587

Informations de copyright

Copyright © 2018 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.

Auteurs

Brian Olshansky (B)

Mercy Hospital, Mason City, Iowa. Electronic address: brian-olshansky@uiowa.edu.

Gourg Atteya (G)

Yale University Medical Center, New Haven, Connecticut.

David Cannom (D)

Hospital of the Good Samaritan, Cedars Sinai Medical Center, Los Angeles, California.

Hein Heidbuchel (H)

Antwerp University and University Hospital, Edegem, Belgium.

Elizabeth V Saarel (EV)

Cleveland Clinic, Cleveland, Ohio.

Ole-Gunnar Anfinsen (OG)

OUS Rikshospitalet, Oslo, Norway.

Alan Cheng (A)

Johns Hopkins Hospital, Baltimore, Maryland.

Michael R Gold (MR)

Medical University of South Carolina, Charleston, South Carolina.

Andreas Müssigbrodt (A)

University of Leipzig, Leipzig, Germany.

Kristen K Patton (KK)

University of Washington, Seattle, Washington.

Leslie A Saxon (LA)

Keck School of Medicine, Los Angeles, California.

Bruce L Wilkoff (BL)

Cleveland Clinic, Cleveland, Ohio.

Rik Willems (R)

University of Leuven, Leuven, Belgium.

James Dziura (J)

Yale University Medical Center, New Haven, Connecticut.

Fangyong Li (F)

Yale University Medical Center, New Haven, Connecticut.

Cynthia Brandt (C)

Yale University Medical Center, New Haven, Connecticut.

Laura Simone (L)

Yale University Medical Center, New Haven, Connecticut.

Matthias Wilhelm (M)

Inselspital, University Hospital, Bern, Switzerland.

Rachel Lampert (R)

Yale University Medical Center, New Haven, Connecticut.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH